Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-29T10:33:44.908Z Has data issue: false hasContentIssue false
  • English
  • Français

Novel Neuroleptics Improve Attentional Functioning in Schizophrenic Patients: Ziprasidone and Aripiprazole

Published online by Cambridge University Press:  07 November 2014

Mark R. Serper  and
James C.Y. Chou
Get access Rights & Permissions [Opens in a new window]

Abstract

Past research has established that traditional neuroleptic treatment improves attentional functioning in schizophrenic (SZ) patients. The present investigation expands on this finding by examining attentional improvement in nine acute SZ patients treated with either the novel neuroleptic ziprasidone or aripiprazole over a 4-week inpatient period. Twelve SZ in patients receiving typical neuroleptic treatment over the same time period served as controls. The results revealed that while all patients showed marked attentional improvement from medication-free baseline to week 4 of treatment, the SZ patients who received novel antipsychotics showed significant improvement on immediate recall and reaction time measures. These results suggest that novel neuroleptic treatment, perhaps through preferential activation of the prefrontal cortical pathways, improves SZ patients' information processing speed and efficiency.

Type
Feature Article
Information
CNS Spectrums , Volume 2 , Issue 8: The Maze of Cognitive Dysfunction , September 1997 , pp. 56 - 59
Copyright
Copyright © Cambridge University Press 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kraepelin, E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: Livingston; 1913.Google Scholar
2.Bleuler, E; Zinkin, J, trans. Dementia Praecox, or the Group of Schizophrenias. New York, NY: International Universities Press; 1950.Google Scholar
3.Nuechterlein, KH, Dawson, M. Information processing and attentional functioning in the course of schizophrenic disorder. Schizophr Bull. 1984;10:160–203.Google Scholar
4.Oltmanns, TF, Neale, JM. Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty? J Abnorm Psychol. 1975;84:205–209.Google Scholar
5.Harvey, PD, Winters, K, Weintraub, S, Neale, JM. Distractibility in children vulnerable to psychopathology. J Abnorm Child Psychol. 1981;90:298–304.Google Scholar
6.Cornblatt, BA, Erlenmeyer-Kimling, L. Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol. 1986;94:470–486.CrossRefGoogle Scholar
7.Nuechterlein, KH, Edell, WS, Norris, M, Dawson, M. Attentional vulnerability indicators, thought disorder and negative symptoms. Schizophr Bull. 1986;12:408–426.Google Scholar
8.Serper, MR. Visual controlled information processing resources and formal thought disorder in schizophrenia and mania. Schizophr Res. 1993;9:55–61.Google Scholar
9.Harvey, PD, Docherty, N, Serper, MR, et al.Cognitive deficits and thought disorder II. An eight month follow-up study. Schizophr Bull. 1990;16:147–151.CrossRefGoogle Scholar
10.Marder, SR, Asarnow, RF, Van Putten, T. Information processing and neuroleptic response in acute and stabilized schizophrenic patients. Psychiatry Res. 1984;13:41–49.Google Scholar
11.Nestor, PG, Faux, SF, McCarley, RW, Sands, SF, Horvath, TB, Peterson, A. Neuroleptics improve sustained attention in schizophrenia: a study using signal detection theory. Neuropsychopharmacology. 1991;4:145–149.Google Scholar
12.Serper, MR, Davidson, M, Harvey, PD. Attentional predictors of clinical change during neuroleptic treatment for schizophrenia. Schizophr Res. 1994;13:65–71.CrossRefGoogle ScholarPubMed
13.Spohn, HE, Lacoursiere, RB, Thompson, K, Coyne, L. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Arch Gen Psychiatry. 1977;34:633–644.CrossRefGoogle ScholarPubMed
14.Rosvold, HE, Mirsky, A, Sarason, I, Bransome, ED, Beck, LH. A continuous performance test of brain damage. Journal of Consulting Psychology (J Consult Clin Psychol). 1956;20:343–350.Google Scholar
15.Orzack, MH, Kornetsky, C, Freedman, H. The effects of daily carphenazine on attention in the schizophrenic patient. Psychopharmacologia. 1967;11:31–38.Google Scholar
16.Oltmanns, TF, Ohayon, J, Neale, JM. The effect of medication and diagnostic criteria on distractibility in schizophrenia. J Psychiatr Res. 1979;17:241–250.Google Scholar
17.Strauss, ME, Lew, MF, Coyle, JT, Tune, LE. Psychopharmacologic and clinical correlates of attention in chronic schizophrenia. Am J Psychiatry. 1985;142:497–499.Google ScholarPubMed
18.Serper, MR, Bergman, RL, Harvey, PD. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res. 1990;32:281–288.CrossRefGoogle ScholarPubMed
19.Serper, MR, Davidson, M, Harvey, PDAttentional and clinical neuroleptic response in schizophrenia: a study with the CPT. Cognitive Neuropsychiatry. In press.Google Scholar
20.Mirsky, AF, Kornetsky, C. The effect of centrally-acting drugs on attention. In: Efron, DH, ed. Psychopharmacology. Bethesda, Md: Public Health Services; 1968.Google Scholar
21.Braff, DL, Huey, L. Methylphenidate-induced information processing deficits in nonschizophrenic patients. Arch Gen Psychiatry. 1988;45:827–832.Google Scholar
22.Cohen, JD, Servan Schreiber, D. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull. 1993;19:85–104.Google Scholar
23.Harvey, PD, Serper, MR. Linguistic and cognitive failures in schizophrenia, a Multivariate analysis. J Nerv Ment Dis. 1990;178:487–493.CrossRefGoogle ScholarPubMed
24.Svensson, TH, Mathe, JM, Andersson, JL, et al.Mode of action of atypical neuroleptics in relation to phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism. J Clin Psychopharmacol. 1995;15:11S–18S.Google Scholar
25.Braff, DL, Sacuzzo, DP. Effects of antipsychotic medication on speed of information processing in schizophrenic patients. Am J Psychiatry. 1982;139:1127–1130.Google ScholarPubMed
26.Swerdlow, NR, Koob, GF. Dopamine, schizophrenia, mania and depression: forward and unified hypothesis of cortico-striato-pallido-thalamic function. Behavior and Brain Sciences. 1987;10:215–217.Google Scholar